Gans Ganapati Email

Co-Founder, Board Member, Chief Business Officer . OrsoBio

Current Roles

Employees:
13
Revenue:
$1M
About
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.
OrsoBio Address
2671 Marshall Drive
Palo Alto, CA
OrsoBio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.